Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for ACADIA PHARMACEUTICALS, INC. · Biopharmaceutical company.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $80,000.00 income · posted Apr 20, 2025

Official filing document

 Bills named in this filing 2
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • S 932
    Give Kids a Chance Act of 2025
 Lobbying activity 2
Health Issues

Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act.

Taxation/Internal Revenue Code

Issues related to the orphan drug tax credit.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem